Please login to the form below

Not currently logged in
Email:
Password:

bone cancer

This page shows the latest bone cancer news and features for those working in and with pharma, biotech and healthcare.

Rare cancer specialists Sierra Oncology acquired by GSK for £1.5bn

Rare cancer specialists Sierra Oncology acquired by GSK for £1.5bn

One of the most notable areas of focus for Sierra Oncology has been myelofibrosis, a fatal cancer of the bone marrow impacting the normal production of blood cells, while it has ... rare forms of cancer while also delivering compelling and certain value

Latest news

More from news
Approximately 1 fully matching, plus 69 partially matching documents found.

Latest Intelligence

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    By Jason Ward. In 2018, more than four million people across Europe were diagnosed with some form of cancer. ... These events may include the return of the cancer or the onset of certain symptoms, such as bone pain from cancer that has spread to the bone.

  • Deal Watch September 2016 Deal Watch September 2016

    Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis. ... Janssen granted Tracon Pharmaceuticals the rights to

  • Case study: Treatment guidance Case study: Treatment guidance

    Mifamurtide is a treatment for children, adolescents and young adults with a rare type of bone cancer, osteosarcoma.

  • Pharma deals during April 2014 Pharma deals during April 2014

    Jakavi (rare bone marrow disorder); Signifor (Cushing's disease) plus 16 products in 24 pivotal trials. ... Additional revenues for these two drugs are also promised in other cancer types not to mention their “combo” potential.

  • The distressing impact of rare diseases The distressing impact of rare diseases

    A US patient with Multiple Hereditary Exostosis (that can cause bone cancer) quoted in the report said: “Finding a doctor that can treat me is the most difficult part.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....